Overall survival in BRCA1 or RAD51C methylated vs mutated ovarian carcinoma following primary treatment with platinum chemotherapy

Authors :: Barbara M. Norquist
Kathy Agnew
M.I. Harrell
Kathryn P. Pennington
Sarah S. Bernards
Elizabeth M. Swisher
Source :: Gynecologic Oncology. 145:24
Publication Year :: 2017
Publisher :: Elsevier BV, 2017.

Subjects :: 0301 basic medicine
Oncology
medicine.medical_specialty
business.industry
Obstetrics and Gynecology
03 medical and health sciences
030104 developmental biology
Ovarian carcinoma
Internal medicine
Platinum chemotherapy
medicine
Cancer research
Overall survival
RAD51C
Primary treatment
business

Full Text Access

Tools